Alessandro Calistri

Alessandro Calistri

Auto-generated profile, based on publicly available information

Alessandro Calistri

Rome, Italy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
KSK. De Smet
K. De Smet
RHR. De Haan
R. De Haan
ACA. Calistri
A. Calistri
PCP.A. Campbell
P.A. Campbell
EEE. Ebramzadeh
E. Ebramzadeh
Richie Harinderjit Singh GillRichie Harinderjit Singh Gill
Richie Harinderjit Singh Gill

1 February 2013 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Open access
PDF file
CSCatherine Van Der Straeten
Catherine Van Der Straeten
GGGeorge Grammatopoulos
George Grammatopoulos
Richie Harinderjit Singh GillRichie Harinderjit Singh Gill
Richie Harinderjit Singh Gill
ACAlessandro Calistri
Alessandro Calistri
PCPatricia Campbell
Patricia Campbell
KSKoen A. De Smet
Koen A. De Smet
The interpretation of metal ion concentrations and their role in clinical management of patients with metal-on-metal implants is still controversial. We questioned whether patients undergoing hip resurfacing with no clinical problems could be differentiated from those with clinical (pain, loss of function) and/or radiographic (component malpositioning, migration, bone loss), problems based on metal ion levels, and if there was a threshold metal level that predicted the need for clinical intervention. Furthermore, we asked if patient and implant factors differed between these functional groups. We retrospectively identified 453 unilateral and 139 bilateral patients with ion measurements at minimum followup of 12 months (mean, 4.3 years; range, 1–12.9 years). Patients were designated as well functioning or poorly functioning based on strict criteria. The acceptable upper levels within the well-functioning group were determined from the 75th percentile plus 1.5× interquartile range. The sensitivity and specificity of these levels to predict clinical problems were calculated. Well-functioning group ions were lower than the poorly functioning group ion levels. The acceptable upper levels were: chromium (Cr) 4.6 μg/L, cobalt (Co) 4.0 μg/L unilateral and Cr 7.4 μg/L, Co 5.0 μg/L bilateral. The specificity of these levels in predicting poor function was high (95%) and sensitivity was low (25%). There were more males in the well-functioning group and more females and smaller femoral components in the poorly functioning group. Metal levels higher than these proposed safe upper limits can predict problems with metal-on-metal resurfacings and are important parameters in the management of at-risk patients. Level II, diagnostic study. See Guidelines for Authors for a complete description of levels of evidence.

1 October 2013 in The Bone & Joint Journal
Verified
Journal Article
Closed access
CSCatherine Van Der Straeten
Catherine Van Der Straeten
DQD. Van Quickenborne
D. Van Quickenborne
BRB. De Roest
B. De Roest
ACA. Calistri
A. Calistri
JVJ. Victor
J. Victor
KSK. De Smet
K. De Smet
A retrospective study was conducted to investigate the changes in metal ion levels in a consecutive series of Birmingham Hip Resurfacings (BHRs) at a minimum ten-year follow-up. We reviewed 250 BHRs implanted in 232 patients between 1998 and 2001. Implant survival, clinical outcome (Harris hip score), radiographs and serum chromium (Cr) and cobalt (Co) ion levels were assessed. Of 232 patients, 18 were dead (five bilateral BHRs), 15 lost to follow-up and ten had been revised. The remaining 202 BHRs in 190 patients (136 men and 54 women; mean age at surgery 50.5 years (17 to 76)) were evaluated at a minimum follow-up of ten years (mean 10.8 years (10 to 13.6)). The overall implant survival at 13.2 years was 92.4% (95% confidence interval 90.8 to 94.0). The mean Harris hip score was 97.7 (median 100; 65 to 100). Median and mean ion levels were low for unilateral resurfacings (Cr: median 1.3 µg/l, mean 1.95 µg/l (< 0.5 to 16.2); Co: median 1.0 µg/l, mean 1.62 µg/l (< 0.5 to 17.3)) and bilateral resurfacings (Cr: median 3.2 µg/l, mean 3.46 µg/l (< 0.5 to 10.0); Co: median 2.3 µg/l, mean 2.66 µg/l (< 0.5 to 9.5)). In 80 unilateral BHRs with sequential ion measurements, Cr and Co levels were found to decrease significantly (p < 0.001) from the initial assessment at a median of six years (4 to 8) to the last assessment at a median of 11 years (9 to 13), with a mean reduction of 1.24 µg/l for Cr and 0.88 µg/l for Co. Three female patients had a > 2.5 µg/l increase of Co ions, associated with head sizes ≤ 50 mm, clinical symptoms and osteolysis. Overall, there was no significant difference in change of ion levels between genders (Cr, p = 0.845; Co, p = 0.310) or component sizes (Cr, p = 0.505; Co, p = 0.370). Higher acetabular component inclination angles correlated with greater change in ion levels (Cr, p = 0.013; Co, p = 0.002). Patients with increased ion levels had lower Harris hip scores (p = 0.038). In conclusion, in well-functioning BHRs the metal ion levels decreased significantly at ten years. An increase > 2.5 µg/l was associated with poor function. Cite this article: Bone Joint J 2013;95-B:1332–8.

1 September 2014 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
ACAlessandro Calistri
Alessandro Calistri
LMLuca Di Martino
Luca Di Martino
MGMichele D. Gurzì
Michele D. Gurzì
MBMarco Bove
Marco Bove
KSKoen De Smet
Koen De Smet
CVCiro Villani
Ciro Villani

15 May 2004 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
Luca PaduaLuca Padua
Luca Padua
Pietro CaliandroPietro Caliandro
Pietro Caliandro
Irene AprileIrene Aprile
Irene Aprile
CPC. Pazzaglia
C. Pazzaglia
RPR. Padua
R. Padua
PTP. Tonali
P. Tonali

1 June 2009
Verified
Journal Article
Closed access
IMIakov MOLAYEM
Iakov MOLAYEM
PPPietro Persiani
Pietro Persiani
LMLucian Lior Marcovici
Lucian Lior Marcovici
SRStefano Rosi
Stefano Rosi
ACAlessandro Calistri
Alessandro Calistri
CVCiro Villani
Ciro Villani